Net Loss Per Common Share (Tables)

9 Months Ended

Sep. 30, 2014

Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	September 30,	September 30,
	2014	2013
Warrants	2,191,487	1,598,968
Options	1,821,142	1,606,501
Series A Preferred Stock	933,333	933,333
Series C Preferred Stock	-	140,000
Series D 4% Preferred Stock	-	2,308,551
Series E Preferred Stock	7,559,998	-
Convertible promissory note	1,878,481	1,896,612
Total	14,384,441	8,483,965

Unissued Common Stock for Possible Future Issuance [Table Text Block]

	September 30,	September 30,
	2014	2013
Exercise of stock warrants	2,191,487	1,598,968
Exercise and future grants of stock options	3,985,605	4,025,319
Conversion of preferred stock	8,493,331	3,381,884
Contingent issuable shares in connection with Sinotop acquisition	-	245,274
Issuable shares from conversion of promissory notes payable	1,878,481	1,896,612
Total	16,548,904	11,148,057